Summaries are drawn from public sources and link to them. HSH does not give a risk rating: read the summary and sources and reach your own view. Unproven allegations are labelled as such. Suppliers can submit a response, which is shown alongside.
Latest full-year results from official filings.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Credible news about incidents, disputes, legal action or restructuring in the last 24 months.
Nov 2025: Nottingham University Hospitals declared a critical incident after its Nervecentre EPR go-live; technical problems caused long periods of downtime amid high demand. The trust apologised and said it was working with Nervecentre to fix performance issues.
Data breaches, cyber incidents, regulator action and assurance status.
No data breaches, cyber incidents or regulator action involving Nervecentre found in HSH's search of the last 24 months. NHS DSPT status not yet checked.
Recalls, safety notices, regulator action and clinical safety concerns.
No product recalls, safety notices or coroners' reports involving Nervecentre found in HSH's search of the last 24 months; see Adverse media for the Nottingham go-live incident.
Contract delivery, go-lives, terminations and disputes.
Mar 2026: York and Scarborough paused its Nervecentre EPR go-live to focus on post-winter recovery, with no new date set. Nottingham's EPR was reported fully working by Feb 2026 after its Nov 2025 issues; Leicester deployed Nervecentre PAS in Nov 2025.